In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes
section 40(a)(i) of the Act, with respect to purchase of vaccine amounting to Rs. 19,12,91,000 made from GlaxoSmithKIine Biological S.A. ('GSK, Bio'}, Belgium, allegedly holding that the appellant -as failed to deduct tax at source from such payment. 2.1 That the CIT(A) erred on facts and in law in allegedly holding that